Biobank for kidney transplant donors and recipients
Official title: Biobank Renal Transplantation University Hospitals Leuven
Run by Universitaire Ziekenhuizen KU Leuven · NCT01331668 · Data updated 2026-11-12
This study is setting up a collection of samples from kidney transplant donors and recipients to help researchers find ways to improve kidney transplant outcomes in the future.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven, BE) |
| Status | Recruiting |
| Started | March 2004 |
| Main results expected | December 2099 |
| Study ends | December 2099 |
| Registry record updated | May 8, 2024 |
| Trial ID | NCT01331668 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who are either donors or recipients of renal transplants.
✕Probably not a fit
Patients who are not involved in kidney transplantation, such as those with other types of organ failure, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on creating a biobank that collects and stores human samples from both kidney transplant donors and recipients. It includes various types of biological specimens such as biopsy tissue, peripheral blood, and urine samples. The collected clinical data and bio-specimens will be used for future translational research projects aimed at improving kidney transplantation outcomes.
Why it matters
Potential benefit: If successful, this biobank could enhance our understanding of kidney transplantation and lead to improved treatments and outcomes for patients with kidney failure.
How similar studies have gone: Other studies involving biobanks for organ transplantation have shown promise in advancing research and improving patient care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * renal transplant recipients/donors Exclusion Criteria: * none
Where it's running
-
Department of Nephrology and Renal Transplantation - University Hospitals Leuven
Leuven, Be, Belgium Recruiting
Study contacts
- Principal investigator: Maarten Naesens, MD, PhD — Universitaire Ziekenhuizen KU Leuven
- Study coordinator: Maarten Naesens, MD, PhD
- Email: maarten.naesens@uzleuven.be
- Phone: 32 16344580
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Omnisol-preserved kidneys before transplant (hypothermic machine perfusion)
This study tests whether using Omnisol during hypothermic machine perfusion before kidney transplant can improve early graft function compared with standard preservation.
-
Kidney and liver blood flow patterns after major trauma
We will use bedside ultrasound to see whether abnormal kidney and liver blood flow patterns occur in adults admitted to the ICU after major trauma and whether those patterns link to acute kidney injury or the need for mechanical ventilation.
-
Home-based exercise to boost fitness for people waiting for a kidney transplant
This study tests whether a 12-week, home-based exercise program plus a wearable activity tracker helps adults on the kidney transplant waiting list increase daily activity and improve physical function.
-
CRISPR-edited donor kidney transplant to reduce rejection risk
This trial will see if donor kidneys edited with CRISPR to turn off key HLA genes can lower rejection in adults with end-stage kidney disease receiving transplants.
-
Effect of Daratumumab on Kidney Diseases Related to Monoclonal Gammopathy
This study is testing whether daratumumab can help improve kidney function and overall health in people with kidney diseases linked to monoclonal gammopathy.
-
Examining amino acid loss in patients undergoing kidney treatment
This study looks at how much amino acid is lost in patients receiving kidney treatment in the ICU compared to those who aren't, to help improve nutrition for people with kidney problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.